Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...

A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...

Main pulmonary artery diameter is a prognostic indicator in patients with pulmonary arterial hypertension without congenital heart disease.

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...

Sotatercept, an activin signaling inhibitor, was associated with improved outcomes in patients with advanced pulmonary ...

Marc Humbert, M.D., Ph.D., professor of respiratory medicine at Université Paris-Saclay and Inserm, believes that recent ...

Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

Pulmonary hypertension is a common complication of systemic sclerosis and generally portends a very poor prognosis. Response to modern therapy for scleroderma-related pulmonary arterial ...

Melatonin, vitamin D, and potassium are just a few of the many supplements that may help lower high blood pressure. High blood pressure is considered the leading modifiable risk factor for heart ...

Pulmonary hypertension (PH) is a disease of the lung vasculature with a grim prognosis. Figure. Proposed mechanism of action. The complementary role of Piezo 1 and Piezo 2 in the pulmonary vasculature ...